Guangjun Nie

National Center for Nanoscience and Technology

Papers

1

Total Citations

1,480

H-Index

1

About

Guangjun Nie is a pioneering figure in nanomedicine and cancer therapeutics, renowned for his groundbreaking work in DNA nanotechnology and targeted drug delivery. His research focuses on engineering intelligent nanoscale systems that can respond to biological cues, particularly for cancer treatment. Nie’s most notable contribution is the development of a DNA nanorobot that functions as a cancer therapeutic in vivo, responding to a molecular trigger to deliver payloads precisely to tumor sites. This landmark study, published in 2018, has garnered over 1,480 citations, underscoring its profound impact on the field. Beyond this, Nie has advanced the design of multifunctional nanomaterials for imaging, diagnosis, and therapy, integrating principles of molecular biology and materials science. His work has been recognized with numerous awards, including the National Natural Science Award of China, and he serves as a leading voice in the international nanomedicine community. For students and researchers, Nie’s research exemplifies how interdisciplinary innovation can translate fundamental science into real-world medical solutions, offering a blueprint for the next generation of smart therapeutics.

Research Focus

Key Achievements

1
H-Index
1
Papers
1,480
Total Citations
1,480
Avg Citations/Paper
🏆 Most Cited Paper
A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo
1,480 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: National Center for Nanoscience and Technology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago